FY2024 EPS Estimates for USPH Raised by Barrington Research

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities researchers at Barrington Research increased their FY2024 earnings estimates for U.S. Physical Therapy in a research report issued to clients and investors on Thursday, November 7th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings of $2.49 per share for the year, up from their prior forecast of $2.20. Barrington Research currently has a “Outperform” rating and a $108.00 target price on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q3 2025 earnings at $0.62 EPS, FY2025 earnings at $2.52 EPS and FY2026 earnings at $2.88 EPS.

Several other research analysts have also recently issued reports on USPH. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Bank of America reiterated a “neutral” rating and issued a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th.

U.S. Physical Therapy Stock Performance

USPH stock opened at $92.17 on Monday. The company has a market cap of $1.39 billion, a P/E ratio of 98.05, a price-to-earnings-growth ratio of 4.40 and a beta of 1.38. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.88. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63. The stock’s fifty day moving average price is $83.92 and its 200-day moving average price is $91.25.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The company had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the firm posted $0.76 EPS.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s payout ratio is 187.23%.

Insider Transactions at U.S. Physical Therapy

In related news, insider Eric Joseph Williams sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $95.84, for a total transaction of $191,680.00. Following the completion of the transaction, the insider now directly owns 14,814 shares in the company, valued at approximately $1,419,773.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Eric Joseph Williams sold 2,000 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $95.84, for a total value of $191,680.00. Following the completion of the transaction, the insider now owns 14,814 shares in the company, valued at $1,419,773.76. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,620 shares of company stock valued at $613,270 over the last quarter. 1.70% of the stock is currently owned by company insiders.

Institutional Trading of U.S. Physical Therapy

Institutional investors have recently made changes to their positions in the business. Canada Pension Plan Investment Board purchased a new position in U.S. Physical Therapy during the second quarter valued at $28,000. Innealta Capital LLC bought a new stake in shares of U.S. Physical Therapy in the second quarter worth about $30,000. Quest Partners LLC increased its holdings in shares of U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after purchasing an additional 337 shares during the last quarter. Quarry LP lifted its position in shares of U.S. Physical Therapy by 1,291.9% in the second quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after buying an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC bought a new position in U.S. Physical Therapy during the second quarter valued at approximately $51,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.